Annual Current Liabilities
$46.59 M
+$21.02 M+82.22%
31 December 2023
Summary:
Monte Rosa Therapeutics annual total current liabilities is currently $46.59 million, with the most recent change of +$21.02 million (+82.22%) on 31 December 2023. During the last 3 years, it has risen by +$17.32 million (+59.15%). GLUE annual current liabilities is now at all-time high.GLUE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$41.64 M
-$707.00 K-1.67%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly total current liabilities is currently $41.64 million, with the most recent change of -$707.00 thousand (-1.67%) on 30 September 2024. Over the past year, it has increased by +$19.03 million (+84.18%). GLUE quarterly current liabilities is now -10.63% below its all-time high of $46.59 million, reached on 31 December 2023.GLUE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.2% | +84.2% |
| 3 y3 years | +59.1% | +226.8% |
| 5 y5 years | - | - |
GLUE Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +180.0% | -10.6% | +233.4% |
| 5 y | 5 years | at high | +985.5% | -10.6% | +358.1% |
| alltime | all time | at high | +985.5% | -10.6% | +358.1% |
Monte Rosa Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $41.64 M(-1.7%) |
| June 2024 | - | $42.35 M(+2.6%) |
| Mar 2024 | - | $41.29 M(-11.4%) |
| Dec 2023 | $46.59 M(+82.2%) | $46.59 M(+106.1%) |
| Sept 2023 | - | $22.61 M(+18.4%) |
| June 2023 | - | $19.09 M(-7.0%) |
| Mar 2023 | - | $20.52 M(-19.8%) |
| Dec 2022 | $25.57 M | $25.57 M(+17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $21.79 M(+47.5%) |
| June 2022 | - | $14.77 M(+18.3%) |
| Mar 2022 | - | $12.49 M(-24.9%) |
| Dec 2021 | $16.64 M(-43.2%) | $16.64 M(+30.6%) |
| Sept 2021 | - | $12.74 M(+18.1%) |
| June 2021 | - | $10.79 M(+18.7%) |
| Mar 2021 | - | $9.09 M(-68.9%) |
| Dec 2020 | $29.27 M(+582.1%) | $29.27 M |
| Dec 2019 | $4.29 M | - |
FAQ
- What is Monte Rosa Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual current liabilities year-on-year change?
- What is Monte Rosa Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly current liabilities year-on-year change?
What is Monte Rosa Therapeutics annual total current liabilities?
The current annual current liabilities of GLUE is $46.59 M
What is the all time high annual current liabilities for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual total current liabilities is $46.59 M
What is Monte Rosa Therapeutics annual current liabilities year-on-year change?
Over the past year, GLUE annual total current liabilities has changed by +$21.02 M (+82.22%)
What is Monte Rosa Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of GLUE is $41.64 M
What is the all time high quarterly current liabilities for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly total current liabilities is $46.59 M
What is Monte Rosa Therapeutics quarterly current liabilities year-on-year change?
Over the past year, GLUE quarterly total current liabilities has changed by +$19.03 M (+84.18%)